Xiaowen Zou

522 total citations
18 papers, 355 citations indexed

About

Xiaowen Zou is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Xiaowen Zou has authored 18 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Xiaowen Zou's work include Bladder and Urothelial Cancer Treatments (3 papers), Computational Drug Discovery Methods (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Xiaowen Zou is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Computational Drug Discovery Methods (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Xiaowen Zou collaborates with scholars based in China, United States and Japan. Xiaowen Zou's co-authors include Sheng Li, Jing Jin, Xiaoguang Chen, Yonghui Chen, Yan Li, Baolian Wang, Jinping Hu, Dan Zhang, Shengyu Zhao and Jie Bai and has published in prestigious journals such as Journal of Medicinal Chemistry, Toxicology and Applied Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Xiaowen Zou

18 papers receiving 348 citations

Peers

Xiaowen Zou

ONCOL

IMMUN

Fanbo Jing China

Gregory R. Kardos United States

Fatema Hersi United Arab Emirates

Bishoy El‐Aarag Egypt

Marinela Bostan Romania

Azra Rabbani‐Chadegani Iran

Dhanir Tailor United States

Chubiao Zhao China

Elisa Robles‐Escajeda United States

Caroline Brandi Schlaepfer Sales Brazil

Fanbo Jing China

Xiaowen Zou

274 ×1.6

102 ×1.1

ONCOL

59 ×0.8

62 ×1.3

29 ×1.0

IMMUN

Citations per year, relative to Xiaowen Zou Xiaowen Zou (= 1×) peers Fanbo Jing

Countries citing papers authored by Xiaowen Zou

Since Specialization

Citations

This map shows the geographic impact of Xiaowen Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen Zou more than expected).

Fields of papers citing papers by Xiaowen Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowen Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen Zou. The network helps show where Xiaowen Zou may publish in the future.

Co-authorship network of co-authors of Xiaowen Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowen Zou. A scholar is included among the top collaborators of Xiaowen Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowen Zou. Xiaowen Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Zhao, Hongyi, Yongxin Gao, Wei Li, et al.. (2022). Design, Synthesis, and Biological Evaluation of Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors for Treating Drug-Resistant Tuberculosis. Journal of Medicinal Chemistry. 65(15). 10534–10553. 24 indexed citations

Jiang, Jianwei, Xiaowen Zou, Yuke Liu, et al.. (2021). Simultaneous Determination of a Novel PD-L1 Inhibitor, IMMH-010, and Its Active Metabolite, YPD-29B, in Rat Biological Matrices by Polarity-Switching Liquid Chromatography-Tandem Mass Spectrometry: Application to ADME Studies. Frontiers in Pharmacology. 12. 677120–677120. 13 indexed citations

Liu, Xiao, Xiaowen Zou, Shuting Wang, et al.. (2021). Metabolism and Interspecies Variation of IMMH-010, a Programmed Cell Death Ligand 1 Inhibitor Prodrug. Pharmaceutics. 13(5). 598–598. 22 indexed citations

Wang, Xu, Sheng Li, Peter Larson, et al.. (2019). A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniae. Journal of Medicinal Chemistry. 62(5). 2305–2332. 25 indexed citations

Bai, Jie, Shengyu Zhao, Xiaoqing Fan, et al.. (2019). Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure–activity relationships. Toxicology and Applied Pharmacology. 369. 49–59. 59 indexed citations

Zhang, Ziqian, Dandan Liu, Xiu‐Yun Song, et al.. (2019). Metabolism of IMM-H004 and Its Pharmacokinetic-Pharmacodynamic Analysis in Cerebral Ischemia/Reperfusion Injured Rats. Frontiers in Pharmacology. 10. 631–631. 2 indexed citations

Zhang, Kehui, Fangfang Lai, Songwen Lin, et al.. (2019). Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases. Journal of Medicinal Chemistry. 62(15). 6992–7014. 68 indexed citations

Wu, Chenglong, Juan Xu, Jinghua Zhang, et al.. (2017). TMEM106a is a Novel Tumor Suppressor in Human Renal Cancer. Kidney & Blood Pressure Research. 42(5). 853–864. 11 indexed citations

Jiang, Jianwei, Ziqian Zhang, Xiaowen Zou, et al.. (2017). Determination of IMM-H004 and its active glucuronide metabolite in rat plasma and Ringer's solution by ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 1074-1075. 16–24. 4 indexed citations

10.

Zou, Xiaowen, Cailing Li, Jianhua Zhong, et al.. (2017). Expression of novel cancer/testis antigen TMEM31 increases during metastatic melanoma progression. Oncology Letters. 13(4). 2269–2273. 8 indexed citations

11.

Wang, Han, Jianhua Zhong, Chenglong Wu, et al.. (2017). Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells. Oncology Reports. 38(2). 917–925. 7 indexed citations

12.

Li, Huixiang, Xiaowen Zou, Yuexuan Wang, et al.. (2017). Dysifragilone A inhibits LPS‑induced RAW264.7 macrophage activation by blocking the p38 MAPK signaling pathway. Molecular Medicine Reports. 17(1). 674–682. 8 indexed citations

13.

Lu, Jing, Pin Zhang, Xiaowen Zou, et al.. (2017). In Silico Prediction of Chemical Toxicity Profile Using Local Lazy Learning. Combinatorial Chemistry & High Throughput Screening. 20(4). 346–353. 8 indexed citations

14.

Zou, Xiaowen, Jianhua Zhong, ZHENGMING SU, et al.. (2015). miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells. Molecular Medicine Reports. 13(1). 994–1002. 26 indexed citations

15.

Zhong, Jianhua, Yan Chen, Xinhui Liao, et al.. (2015). Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer. Tumor Biology. 37(6). 7757–7765. 13 indexed citations

16.

Gao, Bo, Qiang Li, Huaidong Zhou, et al.. (2014). [Application of ICP-mS in the health risk assessment of heavy metals for drinking water sources in reservoirs].. PubMed. 34(5). 1398–402. 8 indexed citations

17.

Liu, Yuchen, Xiangjun Zou, Lei Zhang, et al.. (2014). Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance. Tumor Biology. 35(7). 7217–7223. 28 indexed citations

18.

Zou, Xiaowen, Xiaoli Dong, Limei Wang, et al.. (2014). Preparation of Ni Doped ZnO-TiO₂Composites and Their Enhanced Photocatalytic Activity. International Journal of Photoenergy. 2014. 1–8. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact